NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004

By McCauley John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 389-407

Informa Healthcare

Access to resources Recommend Favorite

Comparison of binding parameters of 1 and 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes

By Nguyen V.H.   Kassiou M.   Johnston G.A.R.   Christie M.J.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 233-240

Elsevier

Access to resources Recommend Favorite

Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 7, 2006-04 ,pp. : 697-709

Bentham Science Publishers

Access to resources Recommend Favorite

[ 3 H]RS79948-197 binding to human, rat, guinea pig and pig 2A -, 2B - and 2C -adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine

By Uhlen S.   Dambrova M.   Nasman J.   Schioth H.B.   Gu Y.   Wikberg-Matsson A.   Wikberg J.E.S.  

European Journal of Pharmacology, Vol. 343, Iss. 1, 1998-02 ,pp. : 93-101

Elsevier

Access to resources Recommend Favorite

GABAA Receptor Subtype-Selective Modulators. I. 2/3-Selective Agonists as Non-Sedating Anxiolytics

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 9, 2011-05 ,pp. : 1176-1202

Bentham Science Publishers

Access to resources Recommend Favorite